Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer

Junichiro Hiro, Yasuhiro Inoue, Yuji Toiyama, Shigeyuki Yoshiyama, Koji Tanaka, Yasuhiko Mohri, Chikao Miki, Masato Kusunoki

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


To evaluate the feasibility of paclitaxel (PTX) radiosensitization for colon cancer, we investigated the cytotoxic and G2/M checkpoint protein (Chk1, Wee1, Bub1, MAD2) effects of 5-fluorouracil (5-FU) or PTX combined with radiation in the human colon cancer cell line LoVo. Cytotoxicity and radiocytotoxicity were evaluated for each drug by the WST-8 colorimetric assay. The IC20 for each drug was determined as a cytotoxic concentration from a survival curve. LoVo cells were exposed to the IC20 of each drug for 24 h and then irradiated. Expressions of the G2/M checkpoint proteins were confirmed by Western blot analysis. Cytotoxicity was induced by 5-FU or PTX alone in a time- and dose-dependent manner. The IC20 of PTX caused higher radiosensitivity than the IC20 of 5-FU (P<0.05). Western blot analysis revealed different expression patterns of the G2/M checkpoint proteins between 5-FU and PTX pretreatments. 5-FU combined with radiation tended to decrease the expressions of all G2/M checkpoint proteins in a time-dependent manner. PTX combined with radiation maintained high expressions of Chk1 and MAD2 proteins for 24 h post-radiation and, in particular, MAD2 protein was strongly induced by PTX with high-dose radiation. PTX showed higher radio-sensitization than 5-FU for the colon cancer cell line LoVo and may be an alternative radiosensitizer to 5-FU in the clinical setting.

Original languageEnglish
Pages (from-to)1029-1034
Number of pages6
JournalOncology reports
Issue number4
Publication statusPublished - 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer'. Together they form a unique fingerprint.

Cite this